This compound is a chiral pharmaceutical intermediate featuring a bicyclic decalin core with a tert-butyldimethylsilyl ether protecting group and a secondary alcohol side chain. It is used in the manufacture of active pharmaceutical ingredients, particularly in research and development settings.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 100928-03-8
Levofloxacin Q-Acid
Ofloxacin impurity reference standard
N-Phenyl-3-(trifluoromethyl)aniline
pharmaceutical intermediate
N-Benzyl-N-methylethanolamine
pharmaceutical intermediate
2-Chloro-1,4-naphthoquinone
pharmaceutical intermediate
Inhoffen Lythgoe diol
Research compound
(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol
pharmaceutical research compound
(1R,3AR,4S,7aR)-7a-methyl-1-((R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl)octahydro-1H-inden-4-ol
Falecalcitriol impurity reference standard
(1R,3AR,4S,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydro-1H-inden-4-ol
fragrance ingredient
(2S)-2-[(1R,3aR,4S,7aR)-4-[tert-butyl(dimethyl)silyl]oxy-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-1-yl]propan-1-ol
DGEVWAPMMLVXQF-QLCXLMDBSA-N
C[C@H](CO)[C@H]1CC[C@@H]2[C@@]1(CCC[C@@H]2O[Si](C)(C)C(C)(C)C)C
—